跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AN-03
首页
药物
AN-03
AN-03
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
HUMANIZED ANTI-HUMAN CD19 ANTIBODIES AND METHODS OF USE
申请人: HOFFMANN LA ROCHE
优先权: 2015
CN
EP
US
5 件公开
Hypoglycemic hyper-branched maltodextrins
申请人: ROQUETTE FRERES
优先权: 2012
EP
US
WO
4 件公开
Processes for the preparation of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
申请人: TANG DATONG
优先权: 2005
US
4 件公开
Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with SOD1 abnormalities
申请人: JULIEN JEAN-PIERRE
优先权: 2006
US
4 件公开
Method
申请人: APPLEWHITE RICHARD J
优先权: 2009
US
4 件公开
Canine influenza virus and vaccine therefore
申请人: CHO YOUNG SHIK
优先权: 2007
CN
US
3 件公开
Pharmaceutical compositions with biological barriers permeation enhancing properties
申请人: FARMATRON LTD
优先权: 2006
EP
US
2 件公开
Method for activating helper T cell
申请人: OTSUKA PHARMA CO LTD
优先权: 2012
CN
US
2 件公开
Composition for use in treating or preventing viral or bacterial infections in a subject undergoing anti-tumor chemotherapy, leukemia treatment or aids therapy comprising L. reuteri LER03 and/or L. salivarius LS06
申请人: BENASSAI CHIARA
优先权: 2014
CN
US
2 件公开
PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING OR PREVENTING CANCER
申请人: INT INST CANCER IMMUNOLOGY INC
优先权: 2021
CN
US
2 件公开
第 1 / 7 页
上一页
下一页
药物
反馈